WPRIM Management System> DCMS> Chinese Journal of Cancer> 2013> 32> 5

Volume: 32 Issue: 5

1. Impact of genetic alterations on mTOR-targeted cancer therapy. Page:270—274
2. Favorable prognosis of female patients with nasopharyngeal carcinoma. Page:283—288
3. Expression of the CXCL12/CXCR4 and CXCL16/CXCR6 axes in cervical intraepithelial neoplasia and cervical cancer. Page:289—296
4. Assessment of quality of life for the patients with cervical cancer at different clinical stages. Page:275—282
5. Targeting the PI3K-AKT-mTOR signaling network in cancer. Page:253—265
6. Molecular targeted agents--where we are and where we are going. Page:225—232
7. Biological functions of decorin in cancer. Page:266—269
8. IGF-1R as an anti-cancer target--trials and tribulations. Page:242—252
9. New evidence-based adaptive clinical trial methods for optimally integrating predictive biomarkers into oncology clinical development programs. Page:233—241

©2019 - Present World Health Organization Regional Office for the Western Pacific. All Rights Reserved.